Reports

Sale

Infection Surveillance Solutions Market

Global Infection Surveillance Solutions Market Size, Share, Growth, Forecast: By Product and Services: Product, Services; By Infection Type: Surgical Site Infection, Urinary Tract Infection, Blood Stream Infection, Others; By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Infection Surveillance Solutions Market Outlook

The global infection surveillance solutions market size reached a value of around USD 612.12 million in 2023, driven by increasing prevalence of infectious diseases. The market is expected to grow at a CAGR of 14.0% during the forecast period of 2024-2032, likely to attain a value of around USD 1992.15 million by 2032.

 

Infection Surveillance Solutions: Introduction

Infections or infectious diseases are the illnesses in humans or animals due to the presence and growth of the pathogens. To prevent the outbreak of these infectious diseases, we need appropriate surveillance solutions. Surveillance of infections means collection of data, analysing the data and deriving inferences, and providing solutions/ measures to prevent the spread of the disease.

 

Infection surveillance solutions include the following systems and tools: Electronic health records (EHRs), syndromic surveillance systems, laboratory information management systems (LIMS), outbreak management systems, data analytics and visualization tools, global surveillance networks and notifiable disease reporting systems.

 

Global Infection Surveillance Solutions Market Analysis

Based on segments, the market is divided into product and services, infection type, end users, and region.

 

Market Breakup by Product and Services

  • Product 
    • Software 
      • Web/Cloud Based 
      • On-premises Based 
  • Services 
    • Product Support and Maintenance Services
    • Training and Consulting Services
    • Implementation Services
    • Other Services

 

Market Breakup by Infection Type

  • Surgical Site Infection 
  • Urinary Tract Infection 
  • Blood Stream Infection 
  • Others

 

Infection Surveillance Solutions Market Breakup by End User

  • Hospitals and Clinics 
  • Ambulatory Surgical Centres 
  • Specialty Centres 
  • Long-term Care Facilities 
  • Others

 

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global Infection Surveillance Solutions Market Scenario

The growth of the market is driven by the increasing prevalence of infectious diseases. During the transmission of an infection, there is a requirement to maintain and curb the spread of the infections, that helps fuelling the growth of this market. In order to prevent the outbreak of infections and virus, like coronavirus, we need infection surveillance solutions in place, so that calculated steps can be taken to prevent the spread of infections.

 

Rapid advances in technology, data analytics tools, real time monitoring, and predictive tools have led to the development of infection surveillance solutions market. Increasing adoption of Electronic Health Records by the healthcare systems have led to the direct linkup of the patient data with the surveillance systems, that can help in easy trace back of the patient with possible symptoms of the infection which can be very beneficial is curbing the spread of the infection.

 

Infection Surveillance Solutions Market: Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global infection surveillance solutions market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

 

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

 

  • Becton, Dickinson and Company 
  • Baxter International Inc. 
  • Wolters Kluwer NV 
  • Premier Inc. 
  • Gojo Industries 
  • BioVigil Healthcare Systems Inc. 
  • Medexter Healthcare GmbH 
  • Koninklijke Philips NV 
  • PeraHealth 
  • Deb Group Ltd. 
  • Cerner Corporation

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Infection Type
  • End User
  • Region
Breakup by Product and Services
  • Product
  • Services
Breakup by Infection Type
  • Surgical Site Infection 
  • Urinary Tract Infection 
  • Blood Stream Infection 
  • Others
Breakup by End User
  • Hospitals and Clinics 
  • Ambulatory Surgical Centres 
  • Specialty Centres 
  • Long-term Care Facilities 
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Becton, Dickinson and Company 
  • Baxter International Inc. 
  • Wolters Kluwer NV 
  • Premier Inc. 
  • Gojo Industries 
  • BioVigil Healthcare Systems Inc. 
  • Medexter Healthcare GmbH 
  • Koninklijke Philips NV 
  • PeraHealth 
  • Deb Group Ltd. 
  • Cerner Corporation

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Infection Surveillance Solutions Market Overview
 
    3.1    Global Infection Surveillance Solutions Market Historical Value (2017-2023) 
    3.2    Global Infection Surveillance Solutions Market Forecast Value (2024-2032)
4    Global Infection Surveillance Solutions Market Landscape
    4.1    Global Infection Surveillance Solutions Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Infection Surveillance Solutions Product Landscape
        4.2.1    Analysis by Product and Services
        4.2.2    Analysis by Infection Type
5    Global Infection Surveillance Solutions Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Infection Surveillance Solutions Market Segmentation 
    6.1    Global Infection Surveillance Solutions Market by Product and Services
        6.1.1    Market Overview
        6.1.2    Product
            6.1.2.1    Software
                6.1.2.1.1    Web/Cloud Based
                6.1.2.1.2    On-premises Based
        6.1.3    Services
            6.1.3.1    Product Support and Maintenance Services
            6.1.3.2    Training and Consulting Services
            6.1.3.3    Implementation Services
            6.1.3.4    Other Services
    6.2    Global Infection Surveillance Solutions Market by Infection Type
        6.2.1    Market Overview
        6.2.2    Surgical Site Infection
        6.2.3    Urinary Tract Infection
        6.2.4    Blood Stream Infection
        6.2.5    Others
    6.3    Global Infection Surveillance Solutions Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals and Clinics
        6.3.3    Ambulatory Surgical Centers
        6.3.4    Specialty Centers
        6.3.5    Long-term Care Facilities
        6.3.6    Others
    6.4    Global Infection Surveillance Solutions Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Infection Surveillance Solutions Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Infection Surveillance Solutions Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Infection Surveillance Solutions Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Infection Surveillance Solutions Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Infection Surveillance Solutions Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Becton, Dickinson and Company
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisition
        17.1.5    Certifications
    17.2    Baxter International Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisition
        17.2.5    Certifications
    17.3    Wolters Kluwer NV
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisition
        17.3.5    Certifications
    17.4    Premier Inc.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisition
        17.4.5    Certifications
    17.5    Gojo Industries
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisition
        17.5.5    Certifications
    17.6    BioVigil Healthcare Systems Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisition
        17.6.5    Certifications
    17.7    Medexter Healthcare GmbH
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisition
        17.7.5    Certifications
    17.8    Koninklijke Philips NV
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisition
        17.8.5    Certifications
    17.9    PeraHealth
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisition
        17.9.5    Certifications
    17.10    Deb Group Ltd.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisition
        17.10.5    Certifications
    17.11    Cerner Corporation
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisition
        17.11.5    Certifications
18    Global Infection Surveillance Solutions Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of USD 612.12 million in 2023, driven by the increasing prevalence of infectious diseases, technological advances in healthcare technology, and focus on data driven healthcare decision making.

The market is anticipated to grow at a CAGR of 14% during the forecast period of 2024-2032 to attain a value of around USD 1992.15 million by 2032.

The growth of the market is driven by factors like the increasing prevalence of infectious diseases, technological advances in healthcare technology, emphasis on infection control and prevention, and focus on data driven healthcare decision making.

The key trends which are bolstering the market growth include integration with digital health technologies, data analysis and predictive decision making, and increasing adoption of real time surveillance.

The products in the market include software, which can further be categorised into web/cloud based and on-premises based. Services can be categorised into product support and maintenance services, training and consulting services, and implementation services, among others.

The infection types can be divided into surgical site infection, urinary tract infection, and blood stream infection, among others.

The end-users can be segmented into hospitals and clinics, ambulatory surgical centres, speciality centres, and long-term care facilities, among others.

The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The key players in the market can be categorised into Becton, Dickinson and Company, Baxter International Inc., Wolters Kluwer NV, Premier Inc., Gojo Industries, BioVigil Healthcare Systems Inc., Medexter Healthcare GmbH, Koninklijke Philips NV, PeraHealth, Deb Group Ltd., and Cerner Corporation.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER